MDR-066

N/A

Report date: 2025/06/11 10:49:47
NME

Base Information

Drug NameMDR-066
Drug Alias NameRAGE inhibitors (Medifron DBT)RAGE antagonists (Roche)RAGE modulator (Digital Biotech)DBT-320MDR-066 +[6] 
ClassificationSmall molecules
Mechanisms of ActionAdvanced glycosylation end product-specific receptor antagonistsNeuroprotectants
TargetsAdvanced glycosylation end product-specific receptor
Therapy Area/IndicationsAlzheimer DiseaseDementia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerlandSouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSeoul National University
China Registration ClassN/A

Develop Information

Active CompaniesRoche Holding LtdMedifron
Inactive CompaniesDigital Biotech Co Ltd
Active IndicationsAlzheimer Disease
Inactive IndicationsDementia

Other Information

ATC CodeN/A
Related LinksN/A